DouYu International Holdings Limited Announces Share Repurchase Program
Get Alerts DOYU Hot Sheet
Join SI Premium – FREE
The Company's share repurchases may be made from time to time on the open market at prevailing market prices, in open-market transactions, privately negotiated transactions or block trades, and/or through other legally permissible means, depending on market conditions and in accordance with the applicable rules and regulations. The timing and conditions of the share repurchases will be subject to various factors including the requirements under Rule 10b-18 and Rule 10b5-1 of the Exchange Act. The Company's board of directors will review the share repurchase program periodically and may authorize adjustments to its terms and size or suspend or discontinue the program. The Company expects to utilize its existing funds to fund repurchases made under this program.
About DouYu International Holdings Limited
Headquartered in
Safe Harbor Statement
This press release contains forward-looking statements. These statements are made under the "safe harbor" provisions of the
Investor Relations Contact
In
DouYu International Holdings Limited
Email: [email protected]
Tel: +86 (10) 6508-0677
Piacente Financial Communications
Email: [email protected]
Tel: +86 (10) 6508-0677
In
Piacente Financial Communications
Email: [email protected]
Tel: +1-212-481-2050
Media Relations Contact
DouYu International Holdings Limited
Email: [email protected]
Tel: +86 (10) 6508-0677
View original content:https://www.prnewswire.com/news-releases/douyu-international-holdings-limited-announces-share-repurchase-program-302023231.html
SOURCE DouYu International Holdings Limited
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Americans for Safe and Effective Medicines Launches to Protect Patients from Illegal Mass Compounding, Counterfeit Drugs, and Misleading Marketing
- Phase II Trial of Cadonilimab(PD-1/CTLA-4) Combination Regimen Launches in the United States for Perioperative Treatment of Gastric Cancer
- RWS launches new linguistic validation service to significantly reduce clinical trial timelines
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Stock BuybackSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share